The NxStage VersiHD home hemodialysis machine offers the convenience of portability for treatment in the comfort of a patientÄ¢¹½´«Ã½™s home.
Home HD is a home-based and therefore a flexible treatment option. Patients dialysing at home can, within the prescribed treatment plan, vary the frequency of dialysis treatment and therefore can benefit from improvement in aspects of quality of life and medical outcomes as described in more detail in the following.1,2
In the following we answer some of your questions, including:
Most people who perform home hemodialysis may extend their treatment time per week, if required, to improve their treatment outcomes. This can be done by performing their therapy more frequentlyÌýat four to seven days a week and/or performing their treatment overnight.
Home hemodialysis gives your patient the freedom to spend more time doing the things they like to do. Whether their passion is fishing or traveling, home hemodialysis has the potential to give them the flexibility to better engage in employment and social life!Ìý7
More frequent hemodialysis is associated with
At home you can adjust frequency and duration of dialysis for your patients.
Shared decision making between patient and physician supports finding the right therapy fit - depending on patientsÄ¢¹½´«Ã½™ therapy needs and lifestyle.
More frequent and / or long duration hemodialysis has been shown to improve clinical outcomes.
With HHD, a highly effective treatment is moving in, that today can be set up and run conveniently in the patientsÄ¢¹½´«Ã½™ homes. From training videos for caregivers and patients to home setup by a team of specialists, we get it right from the start.
Once HHD therapy is running, we offer a range of services to support you in conveniently reducing your workload and reducing treatment interruptions.
1ÌýMiller BW et al. Blood Purif 2018; 45(1-3):224-229
2ÌýTennankore KK et al. Nat Rev Nephrol 2012; 8(9):515-522
3ÌýMcCullough PA et al. Am J Kidney Dis 2016; 68(5):5Ä¢¹½´«Ã½“14
4ÌýSusantitaphong P et al. Am J Kidney Dis 2012; 59(5):689Ä¢¹½´«Ã½“699
5ÌýKotanko P Hemodial Int 2015; 19(3):386-401
6ÌýWatanabe Y Hemodial Int 2014; 18(1):32-38
7ÌýWalker RC et al. Am J Kidney Dis 2015; 65(3):451-463
8ÌýFinkelstein FO et al. Kidney Int 2012; 82(5):561-569
9ÌýJaber BL et al. Am J Kidney Dis 2010; 56(3):531-539Ìý
10ÌýWalker RC et al. Clin Outcomes Res 2017; 9:149-161
11ÌýCulleton BF et al. JAMA 2007; 298(11):1291-1299
12ÌýPortales-Castillo I et al. Kidney360 2020; 1(12):1447-1455